Terms: = Brain cancer AND HMGA2, HMGI-C, 8091, ENSG00000149948, LIPO, HMGIC, BABL
71 results:
1. Automatic segmentation of hepatocellular carcinoma on dynamic contrast-enhanced MRI based on deep learning.
Luo X; Li P; Chen H; Zhou K; Piao S; Yang L; Hu B; Geng D
Phys Med Biol; 2024 Mar; 69(6):. PubMed ID: 38330492
[No Abstract] [Full Text] [Related]
2. Epigenomic and transcriptomic landscaping unraveled candidate repositioned therapeutics for non-functioning pituitary neuroendocrine tumors.
Aydin B; Beklen H; Arga KY; Bayrakli F; Turanli B
J Endocrinol Invest; 2023 Apr; 46(4):727-747. PubMed ID: 36306107
[TBL] [Abstract] [Full Text] [Related]
3. Chromosomal Translocation t(5;12)(p13;q14) Leading to Fusion of High-mobility Group AT-hook 2 Gene With Intergenic Sequences From Chromosome Sub-Band 5p13.2 in Benign Myoid Neoplasms of the Breast: A Second Case.
Panagopoulos I; Gorunova L; Andersen K; Lund-Iversen M; Hognestad HR; Lobmaier I; Micci F; Heim S
Cancer Genomics Proteomics; 2022; 19(4):445-455. PubMed ID: 35732319
[TBL] [Abstract] [Full Text] [Related]
4. MicroRNA 3928 Suppresses Glioblastoma through Downregulation of Several Oncogenes and Upregulation of p53.
Mulcahy EQX; Zhang Y; Colόn RR; Cain SR; Gibert MK; Dube CJ; Hafner M; Abounader R
Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409289
[TBL] [Abstract] [Full Text] [Related]
5. Exosomal hmga2 protein from EBV-positive NPC cells destroys vascular endothelial barriers and induces endothelial-to-mesenchymal transition to promote metastasis.
Li DK; Chen XR; Wang LN; Wang JH; Li JK; Zhou ZY; Li X; Cai LB; Zhong SS; Zhang JJ; Zeng YM; Zhang QB; Fu XY; Lyu XM; Li MY; Huang ZX; Yao KT
Cancer Gene Ther; 2022 Oct; 29(10):1439-1451. PubMed ID: 35388172
[TBL] [Abstract] [Full Text] [Related]
6. Structure-based discovery of a specific SHP2 inhibitor with enhanced blood-brain barrier penetration from PubChem database.
Ma Y; Li WY; Sun T; Zhang L; Lu XH; Yang B; Wang RL
Bioorg Chem; 2022 Apr; 121():105648. PubMed ID: 35180489
[TBL] [Abstract] [Full Text] [Related]
7. Targeting immunoliposomes to EGFR-positive glioblastoma.
Kasenda B; König D; Manni M; Ritschard R; Duthaler U; Bartoszek E; Bärenwaldt A; Deuster S; Hutter G; Cordier D; Mariani L; Hench J; Frank S; Krähenbühl S; Zippelius A; Rochlitz C; Mamot C; Wicki A; Läubli H
ESMO Open; 2022 Feb; 7(1):100365. PubMed ID: 34998092
[TBL] [Abstract] [Full Text] [Related]
8. hmga2 contributes to vascular development and sprouting angiogenesis by promoting IGFBP2 production.
Wang J; Chen Y; Zeng Z; Feng R; Wang Q; Zhang Q; Sun K; Chen AF; Lu Y; Yu Y
Exp Cell Res; 2021 Nov; 408(1):112831. PubMed ID: 34547256
[TBL] [Abstract] [Full Text] [Related]
9. [Development of Biomembrane-mimetic Nanoparticles for the Treatment of Ischemic Stroke].
Fukuta T
Yakugaku Zasshi; 2021; 141(9):1071-1078. PubMed ID: 34471008
[TBL] [Abstract] [Full Text] [Related]
10. Sphingosine 1-Phosphate liposomes for Targeted Nitric Oxide Delivery to Mediate Anticancer Effects against brain Glioma Tumors.
Liu Y; Wang X; Li J; Tang J; Li B; Zhang Y; Gu N; Yang F
Adv Mater; 2021 Jul; 33(30):e2101701. PubMed ID: 34106489
[TBL] [Abstract] [Full Text] [Related]
11. Positioning of nucleosomes containing γ-H2AX precedes active DNA demethylation and transcription initiation.
Dobersch S; Rubio K; Singh I; Günther S; Graumann J; Cordero J; Castillo-Negrete R; Huynh MB; Mehta A; Braubach P; Cabrera-Fuentes H; Bernhagen J; Chao CM; Bellusci S; Günther A; Preissner KT; Kugel S; Dobreva G; Wygrecka M; Braun T; Papy-Garcia D; Barreto G
Nat Commun; 2021 Feb; 12(1):1072. PubMed ID: 33594057
[TBL] [Abstract] [Full Text] [Related]
12. An autopsy case of prostatic rhabdomyosarcoma with DICER1 hotspot mutation.
Miyama Y; Makise N; Miyakawa J; Kume H; Fukayama M; Ushiku T
Pathol Int; 2021 Jan; 71(1):102-108. PubMed ID: 33112496
[TBL] [Abstract] [Full Text] [Related]
13. Remodeling tumor immune microenvironment (TIME) for glioma therapy using multi-targeting liposomal codelivery.
Zheng Z; Zhang J; Jiang J; He Y; Zhang W; Mo X; Kang X; Xu Q; Wang B; Huang Y
J Immunother Cancer; 2020 Aug; 8(2):. PubMed ID: 32817393
[TBL] [Abstract] [Full Text] [Related]
14. High hmga2 expression without gene rearrangement in meningiomas.
Nagaishi M; Nakae R; Matsumoto Y; Fujii Y; Sugiura Y; Takigawa T; Suzuki K
Neuropathology; 2020 Dec; 40(6):540-545. PubMed ID: 32812281
[TBL] [Abstract] [Full Text] [Related]
15. Mir-370-3p Impairs Glioblastoma Stem-Like Cell Malignancy Regulating a Complex Interplay between hmga2/HIF1A and the Oncogenic Long Non-Coding RNA (lncRNA) NEAT1.
Lulli V; Buccarelli M; Ilari R; Castellani G; De Dominicis C; Di Giamberardino A; D Alessandris QG; Giannetti S; Martini M; Stumpo V; Boe A; De Luca G; Biffoni M; Marziali G; Pallini R; Ricci-Vitiani L
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443824
[TBL] [Abstract] [Full Text] [Related]
16. Verbascoside inhibits progression of glioblastoma cells by promoting Let-7g-5p and down-regulating hmga2 via Wnt/beta-catenin signalling blockade.
Jia WQ; Zhu JW; Yang CY; Ma J; Pu TY; Han GQ; Zou MM; Xu RX
J Cell Mol Med; 2020 Mar; 24(5):2901-2916. PubMed ID: 32000296
[TBL] [Abstract] [Full Text] [Related]
17. RPSAP52 lncRNA Inhibits p21Waf1/CIP Expression by Interacting With the RNA Binding Protein HuR.
D'Angelo D; Arra C; Fusco A
Oncol Res; 2020 Mar; 28(2):191-201. PubMed ID: 31831098
[TBL] [Abstract] [Full Text] [Related]
18. Ca
Sharma S; Wu SY; Jimenez H; Xing F; Zhu D; Liu Y; Wu K; Tyagi A; Zhao D; Lo HW; Metheny-Barlow L; Sun P; Bourland JD; Chan MD; Thomas A; Barbault A; D'Agostino RB; Whitlow CT; Kirchner V; Blackman C; Pasche B; Watabe K
EBioMedicine; 2019 Jun; 44():194-208. PubMed ID: 31129098
[TBL] [Abstract] [Full Text] [Related]
19. RPSAP52 lncRNA is overexpressed in pituitary tumors and promotes cell proliferation by acting as miRNA sponge for HMGA proteins.
D'Angelo D; Mussnich P; Sepe R; Raia M; Del Vecchio L; Cappabianca P; Pellecchia S; Petrosino S; Saggio S; Solari D; Fraggetta F; Fusco A
J Mol Med (Berl); 2019 Jul; 97(7):1019-1032. PubMed ID: 31076808
[TBL] [Abstract] [Full Text] [Related]
20. Differential Expression of HMGA1 and hmga2 in pituitary neuroendocrine tumors.
Portovedo S; Gaido N; de Almeida Nunes B; Nascimento AG; Rocha A; Magalhães M; Nascimento GC; Pires de Carvalho D; Soares P; Takiya C; Faria MDS; Miranda-Alves L
Mol Cell Endocrinol; 2019 Jun; 490():80-87. PubMed ID: 30999005
[TBL] [Abstract] [Full Text] [Related]
[Next]
